z-logo
open-access-imgOpen Access
Modern induction chemotherapy before chemoradiation for bulky locally-advanced nonsmall cell lung cancer improves survival
Author(s) -
SalmaK Jabbour,
Inaya Ahmed,
Adam Ferro,
Rekha Baby,
Jyoti Malhotra,
Alan Cohler,
John Langenfeld,
Joseph Aisner,
Wei Zou
Publication year - 2016
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.177214
Subject(s) - medicine , carboplatin , induction chemotherapy , oncology , chemotherapy , lung cancer , chemoradiotherapy , univariate analysis , radiation therapy , multivariate analysis , surgery , cisplatin
We seek to investigate whether carboplatin-based induction chemotherapy before modern day concurrent chemoradiotherapy (CCRT) improves survival in patients with bulky, locally advanced nonsmall cell lung cancer (NSCLC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom